Actions
Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union
Affiliations
- PMID: 35657672
- PMCID: PMC9347686
- DOI: 10.1111/apa.16442
Item in Clipboard
Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union
Acta Paediatr.
2023 Feb.
Free PMC article
No abstract available
Conflict of interest statement
Calvo and Neth are sub‐investigators in a clinical trial of the Janssen COVID‐19 vaccine in adolescents. Dal‐Ré has no interest to declare.
Similar articles
-
Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years.JAMA Netw Open. 2022 Oct 3;5(10):e2237140. doi: 10.1001/jamanetworkopen.2022.37140. JAMA Netw Open. 2022. PMID: 36255723 Free PMC article.
-
BNT162b2 mRNA COVID-19 Vaccine: First Approval.Drugs. 2021 Mar;81(4):495-501. doi: 10.1007/s40265-021-01480-7. Drugs. 2021. PMID: 33683637 Free PMC article. Review.
-
Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines.Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5. Epub 2021 Jan 22. Panminerva Med. 2022. PMID: 33480519 No abstract available.
-
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.N Engl J Med. 2022 Mar 24;386(12):1192. doi: 10.1056/NEJMc2201556. Epub 2022 Mar 2. N Engl J Med. 2022. PMID: 35235723 No abstract available.
-
Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.J Pharm Pract. 2022 Dec;35(6):947-951. doi: 10.1177/08971900211009650. Epub 2021 Apr 12. J Pharm Pract. 2022. PMID: 33840294 Review.
References
-
- deSante‐Bertkau JE, Knilans TK, Persad G, Zettler PJ, Fernandez Lynch H, Antommaria AHM. Off‐label prescription of COVID‐19 vaccines in children: clinical, ethical, and legal issues. Pediatrics. 2022;149(2):e2021054578. - PubMed
-
- European Parliament . Parliamentary questions. E–006615/2020. Rule 138, Jean Paul Garraud (ID). Subject: civil liability for COVID‐19 vaccines. 2020. https://www.europarl.europa.eu/doceo/document/E‐9‐2020‐006615_EN.html. Accessed February 10, 2022.
-
- European Parliament . Motion for a resolution pursuant to Rule 143 of the Rules of Procedure on creating a European compensation fund for victims of the ‘COVID‐19 vaccines’. B9‐0475/2021. 2021. https://www.europarl.europa.eu/doceo/document/B‐9‐2021‐0475_EN.html. Accessed February 10, 2022.
-
- European Centre for Disease Prevention and Control . COVID‐19 vaccine tracker. 2022. https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID‐19/vaccine.... Accessed February 10, 2022.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical